James A. Geraghty, Director at Fulcrum Therapeutics, Inc. (FULC), bought 10,000 shares at $9.16 ($92K) on 2021-06-28, disclosed to the SEC on 2021-06-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IDRA | BUY | 2018-08-08 | $56K | — | Filing → |
| PIRS | BUY | 2018-05-16 | $58K | — | Filing → |
| PIRS | BUY | 2017-08-17 | $48K | — | Filing → |